Exploring the effect of antenatal depression treatment on children's epigenetic profiles: findings from a pilot randomized controlled trial.
Antidepressive Agents
/ pharmacology
Child
Child, Preschool
Cognitive Behavioral Therapy
/ methods
DNA Methylation
/ drug effects
Depression
/ therapy
Epigenesis, Genetic
/ drug effects
Female
Humans
Male
Pilot Projects
Pregnancy
Prenatal Care
Prenatal Exposure Delayed Effects
/ genetics
Promoter Regions, Genetic
Severity of Illness Index
Whole Genome Sequencing
/ methods
Antenatal depression
CBT
DNA methylation
Epigenetics
Neurodevelopment
Programming
Journal
Clinical epigenetics
ISSN: 1868-7083
Titre abrégé: Clin Epigenetics
Pays: Germany
ID NLM: 101516977
Informations de publication
Date de publication:
04 02 2019
04 02 2019
Historique:
received:
28
06
2018
accepted:
14
01
2019
entrez:
6
2
2019
pubmed:
6
2
2019
medline:
22
1
2020
Statut:
epublish
Résumé
Children prenatally exposed to maternal depression more often show behavioral and emotional problems compared to unexposed children, possibly through epigenetic alterations. Current evidence is largely based on animal and observational human studies. Therefore, evidence from experimental human studies is needed. In this follow-up of a small randomized controlled trial (RCT), DNA-methylation was compared between children of women who had received cognitive behavioral therapy (CBT) for antenatal depression and children of women who had received treatment as usual (TAU). Originally, 54 women were allocated to CBT or TAU. A beneficial treatment effect was found on women's mood symptoms. We describe DNA methylation findings in buccal swab DNA of the 3-7-year-old children (CBT(N) = 12, TAU(N) = 11), at a genome-wide level at 770,668 CpG sites and at 729 CpG sites spanning 16 a priori selected candidate genes, including the glucocorticoid receptor (NR3C1). We additionally explored associations with women's baseline depression and anxiety symptoms and offspring DNA methylation, regardless of treatment. Children from the CBT group had overall lower DNA methylation compared to children from the TAU group (mean ∆β = - 0.028, 95% CI - 0.035 to - 0.022). Although 68% of the promoter-associated NR3C1 probes were less methylated in the CBT group, with cg26464411 as top most differentially methylated CpG site (p = 0.038), mean DNA methylation of all NR3C1 promoter-associated probes did not differ significantly between the CBT and TAU groups (mean ∆β = 0.002, 95%CI - 0.010 to 0.011). None of the effects survived correction for multiple testing. There were no differences in mean DNA methylation between the children born to women with more severe depression or anxiety compared to children born to women with mild symptoms of depression or anxiety at baseline (mean ∆β (depression) = 0.0008, 95% CI - 0.007 to 0.008; mean ∆β (anxiety) = 0.0002, 95% CI - 0.004 to 0.005). We found preliminary evidence of a possible effect of CBT during pregnancy on widespread methylation in children's genomes and a trend toward lower methylation of a CpG site previously shown by others to be linked to depression and child maltreatment. However, none of the effects survived correction for multiple testing and larger studies are warranted. Trial registration of the original RCT: ACTRN12607000397415 . Registered on 2 August 2007.
Sections du résumé
BACKGROUND
Children prenatally exposed to maternal depression more often show behavioral and emotional problems compared to unexposed children, possibly through epigenetic alterations. Current evidence is largely based on animal and observational human studies. Therefore, evidence from experimental human studies is needed. In this follow-up of a small randomized controlled trial (RCT), DNA-methylation was compared between children of women who had received cognitive behavioral therapy (CBT) for antenatal depression and children of women who had received treatment as usual (TAU). Originally, 54 women were allocated to CBT or TAU. A beneficial treatment effect was found on women's mood symptoms.
FINDINGS
We describe DNA methylation findings in buccal swab DNA of the 3-7-year-old children (CBT(N) = 12, TAU(N) = 11), at a genome-wide level at 770,668 CpG sites and at 729 CpG sites spanning 16 a priori selected candidate genes, including the glucocorticoid receptor (NR3C1). We additionally explored associations with women's baseline depression and anxiety symptoms and offspring DNA methylation, regardless of treatment. Children from the CBT group had overall lower DNA methylation compared to children from the TAU group (mean ∆β = - 0.028, 95% CI - 0.035 to - 0.022). Although 68% of the promoter-associated NR3C1 probes were less methylated in the CBT group, with cg26464411 as top most differentially methylated CpG site (p = 0.038), mean DNA methylation of all NR3C1 promoter-associated probes did not differ significantly between the CBT and TAU groups (mean ∆β = 0.002, 95%CI - 0.010 to 0.011). None of the effects survived correction for multiple testing. There were no differences in mean DNA methylation between the children born to women with more severe depression or anxiety compared to children born to women with mild symptoms of depression or anxiety at baseline (mean ∆β (depression) = 0.0008, 95% CI - 0.007 to 0.008; mean ∆β (anxiety) = 0.0002, 95% CI - 0.004 to 0.005).
CONCLUSION
We found preliminary evidence of a possible effect of CBT during pregnancy on widespread methylation in children's genomes and a trend toward lower methylation of a CpG site previously shown by others to be linked to depression and child maltreatment. However, none of the effects survived correction for multiple testing and larger studies are warranted.
TRIAL REGISTRATION
Trial registration of the original RCT: ACTRN12607000397415 . Registered on 2 August 2007.
Identifiants
pubmed: 30717815
doi: 10.1186/s13148-019-0616-2
pii: 10.1186/s13148-019-0616-2
pmc: PMC6360775
doi:
Substances chimiques
Antidepressive Agents
0
Banques de données
ANZCTR
['ACTRN12607000397415']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
18Références
Arch Gen Psychiatry. 1961 Jun;4:561-71
pubmed: 13688369
Epigenetics. 2008 Mar-Apr;3(2):97-106
pubmed: 18536531
BJOG. 2008 Jul;115(8):1043-51
pubmed: 18651886
Obstet Gynecol. 2004 Apr;103(4):698-709
pubmed: 15051562
J Consult Clin Psychol. 1988 Dec;56(6):893-7
pubmed: 3204199
Infant Behav Dev. 2006 Jul;29(3):445-55
pubmed: 17138297
Ann Nutr Metab. 2014;64(3-4):203-7
pubmed: 25300261
Am J Hum Genet. 2016 Apr 7;98(4):680-96
pubmed: 27040690
Basic Clin Pharmacol Toxicol. 2017 Sep;121 Suppl 3:93-101
pubmed: 27901320
Lancet. 2014 Jun 7;383(9933):1952-4
pubmed: 24630775
BMC Bioinformatics. 2012 May 08;13:86
pubmed: 22568884
CMAJ. 2014 Oct 21;186(15):1153-7
pubmed: 24778353
Depress Anxiety. 2011 Aug;28(8):696-702
pubmed: 21769997
Sci Rep. 2017 Mar 16;7:44445
pubmed: 28300138
Epigenetics. 2015;10(10):893-902
pubmed: 26327302
Transl Psychiatry. 2011 Jul 19;1:e21
pubmed: 22832523
Int J Epidemiol. 2015 Aug;44(4):1211-23
pubmed: 25944819
ILAR J. 2012;53(3-4):279-88
pubmed: 23744967
Child Dev. 2010 Jan-Feb;81(1):149-65
pubmed: 20331659
J Affect Disord. 2012 Feb;136(3):680-92
pubmed: 22036793
Soc Psychiatry Psychiatr Epidemiol. 2013 Aug;48(8):1335-45
pubmed: 23248031
Genome Biol. 2016 Oct 7;17(1):208
pubmed: 27717381
J Abnorm Child Psychol. 2014 Jan;42(1):161-71
pubmed: 23748337
J Clin Psychiatry. 2011 Mar;72(3):378-87
pubmed: 21208585
J Neurosci. 2008 Sep 3;28(36):9055-65
pubmed: 18768700
Epigenetics. 2012 Aug;7(8):853-7
pubmed: 22810058
Psychoneuroendocrinology. 2012 Aug;37(8):1224-33
pubmed: 22265195
Transl Psychiatry. 2014 Apr 08;4:e381
pubmed: 24713862
Epigenomics. 2013 Feb;5(1):1-4
pubmed: 23414310
J Affect Disord. 2009 Mar;113(3):236-43
pubmed: 18602698
Epigenomics. 2017 Mar;9(3):313-332
pubmed: 28140666
JAMA Psychiatry. 2013 Dec;70(12):1312-9
pubmed: 24108418
Am J Physiol Regul Integr Comp Physiol. 2005 Jan;288(1):R34-8
pubmed: 15178540
J Child Psychol Psychiatry. 2003 Sep;44(6):810-8
pubmed: 12959490
Epigenetics. 2011 Dec;6(12):1498-504
pubmed: 22139580
BMJ. 2006 Apr 22;332(7547):969-71
pubmed: 16627519
Arch Womens Ment Health. 2015 Oct;18(5):717-30
pubmed: 25709044
Transl Psychiatry. 2015 May 26;5:e571
pubmed: 26080088
J Dev Orig Health Dis. 2016 Dec;7(6):565-573
pubmed: 27573131
J Child Psychol Psychiatry. 2013 May;54(5):591-600
pubmed: 23215861
Nord J Psychiatry. 2011 Dec;65(6):414-8
pubmed: 21728782
Genome Biol. 2012 Jun 15;13(6):R44
pubmed: 22703947